Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,763	2,421	2,054	1,275	81	164
Market Cap Growth	-19.91%	17.84%	61.12%	1478.46%	-50.66%	-78.69%
Enterprise Value	2,288	2,167	1,815	1,105	66.18	142.59
Last Close Price	53.01	46.30	44.95	40.25	9.90	30.75
PE Ratio	30.00	118.72	-	-	-	-
Forward PE	11.16	13.68	-	-	-	-
PS Ratio	9.69	12.71	-	-	-	-
PB Ratio	5.53	5.38	8.38	8.10	7.81	9.20
P/TBV Ratio	5.69	5.39	7.37	4.21	8.03	9.19
P/FCF Ratio	26.21	51.81	-	-	-	-
P/OCF Ratio	26.18	51.73	-	-	-	-
EV/Sales Ratio	8.03	11.38	-	-	-	-
EV/EBITDA Ratio	25.00	189.59	-	-	-	-
EV/EBIT Ratio	25.57	230.21	-	-	-	-
EV/FCF Ratio	21.71	46.38	-	-	-	-
Debt / Equity Ratio	0.11	0.12	0.21	0.00	0	0.01
Debt / EBITDA Ratio	0.61	4.60	-	-	-	-
Debt / FCF Ratio	0.52	1.13	-	-	-	-
Net Debt / Equity Ratio	-0.41	-0.56	-0.97	-1.07	-1.40	-1.17
Net Debt / EBITDA Ratio	-2.28	-22.13	1.29	4.29	0.64	0.71
Net Debt / FCF Ratio	-1.91	-5.41	3.44	6.79	0.70	0.75
Asset Turnover	0.49	0.43	0	0	0	0
Inventory Turnover	0.24	0.36	-	-	-	-
Quick Ratio	5.22	5.44	15.55	14.75	2.00	2.66
Current Ratio	5.62	5.80	15.68	14.89	2.14	2.80
Return on Equity (ROE)	20.31%	6.01%	-87.35%	-46.45%	-171.05%	-97.60%
Return on Assets (ROA)	14.22%	2.10%	-73.36%	-39.95%	-78.64%	-62.72%
Return on Invested Capital (ROIC)	29.20%	7.18%	-1379.43%	-1262.86%	-404.32%	-440.27%
Return on Capital Employed (ROCE)	16.42%	2.31%	-77.97%	-43.94%	-104.42%	-75.15%
Earnings Yield	3.46%	0.84%	-	-	-	-
FCF Yield	3.82%	1.93%	-	-	-	-
Buyback Yield / Dilution	-26.81%	-30.39%	-143.61%	-96.40%	-57.90%	-27.39%
Total Shareholder Return	-26.81%	-30.39%	-143.61%	-96.40%	-57.90%	-27.39%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q